BOD
Consumer Discretionary Distribution & Retail
BOD Science
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 24 Oct 2023
- Reported shorts
- 1.7K
- Shares on issue
- 177.339M
BOD Science (BOD) company profile
Profile, insiders and operations
Company
AI-generated research profile of BOD Science
Medicinal Cannabis
Life Sciences
Healthcare
Biotechnology
Consumer Health
Bod Science Limited (ASX:BOD) is a global life science healthcare company specializing in cannabis-centric products and solutions. The company is dedicated to innovating and transforming lives by delivering premium, proven, and trusted cannabinoid-based medications. It actively engages in clinical research, such as the CAN-REST study for insomnia, and provides comprehensive resources for accessing medicinal cannabis and informing both consumers and medical professionals.
BOD intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required